BiogenBIIB , a well known name in the multiple sclerosis (MS) market, will be reporting third quarter 2015 earnings results on Oct 21, before the market opens. Biogen’s performance has been mostly positive with the company surpassing expectations in
Will Tecfidera Slowdown Hit Biogen (BIIB) Earnings in Q3?
